Increased White Matter Inflammation in Aging- and Alzheimer's Disease Brain

Divya Raj1, Zhuoran Yin1,2, Marjolein Breur3

  • 1Department of Neuroscience, Section Medical Physiology, University Medical Center Groningen, University of GroningenGroningen, Netherlands.

Insights

Microglia-driven neuroinflammation predominantly affects white matter in aging and Alzheimer

Area of Science:

  • Neuroscience
  • Immunology
  • Aging Research

Background:

  • Chronic neuroinflammation, mediated by microglia, is crucial in aging and neurodegeneration.
  • The spatial distribution of microglia-induced neuroinflammation (global vs. regional) remains unclear.

Purpose of the Study:

  • To investigate microglia activity in different brain regions during healthy aging and Alzheimer's disease (AD).
  • To determine if neuroinflammation is localized or widespread in the aging and AD brain.

Main Methods:

  • Analysis of gene expression and protein markers in purified microglia from aging mouse brains.
  • Quantification of microglial proteins (CD68, HLA-DR) in human postmortem white matter.
  • Positron emission tomography (PET) imaging using [11C]-(R)-PK11195 in human subjects.
  • Examination of human brain tissue from healthy aging, early-onset AD (EOAD), and late-onset AD (LOAD) cases.

Main Results:

  • Aging mouse microglia show upregulated pro-inflammatory, phagocytic, and lipid homeostasis genes, especially in white matter.
  • Human white matter exhibits age-dependent increases in microglial activation markers (CD68, HLA-DR) starting in middle age.
  • PET imaging confirms increased microglia activity in aging white matter.
  • Elevated microglia activity is prominent in white matter of EOAD brains and similar to aged, clinically silent AD cases in LOAD.

Conclusions:

  • Microglia-induced neuroinflammation is predominantly localized in the white matter during aging and in early-onset Alzheimer's disease.
  • This white matter inflammation may drive neurodegeneration and serve as a prognostic marker for aging and AD progression.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
894
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
547
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.7K